HLX vs CLOV

For growth investors, Clover Health Investments, Corp.

(CLOV) is the stronger pick with 40. 3% revenue growth year-over-year, versus -4. 9% for Helix Energy Solutions Group, Inc. (HLX). Helix Energy Solutions Group, Inc. (HLX) offers the better valuation at 47. 9x trailing P/E (36. 2x forward), making it the more compelling value choice. Analysts rate Helix Energy Solutions Group, Inc. (HLX) a "Buy" — based on 22 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On forward P/E, Helix Energy Solutions Group, Inc.

is actually cheaper at 36. 2x.

Over the past 5 years, Helix Energy Solutions Group, Inc.

(HLX) delivered a total return of +90. 0%, compared to -49. 1% for Clover Health Investments, Corp. (CLOV). Over 10 years, the gap is even starker: HLX returned +37. 9% versus CLOV's -66. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Helix Energy Solutions Group, Inc.

(HLX) is the lower-risk stock at 0. 78β versus Clover Health Investments, Corp. 's 1. 36β — meaning CLOV is approximately 74% more volatile than HLX relative to the S&P 500.

By revenue growth (latest reported year), Clover Health Investments, Corp.

(CLOV) is pulling ahead at 40. 3% versus -4. 9% for Helix Energy Solutions Group, Inc. (HLX). On earnings-per-share growth, the picture is similar: Helix Energy Solutions Group, Inc. grew EPS -41. 7% year-over-year, compared to -93. 6% for Clover Health Investments, Corp.. Over a 3-year CAGR, CLOV leads at 20. 6% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Helix Energy Solutions Group, Inc.

(HLX) is the more profitable company, earning 2. 4% net margin versus -4. 4% for Clover Health Investments, Corp. — meaning it keeps 2. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: HLX leads at 5. 0% versus -4. 4% for CLOV. At the gross margin level — before operating expenses — CLOV leads at 18. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, Helix Energy Solutions Group, Inc.

(HLX) trades at 36. 2x forward P/E versus 89. 7x for Clover Health Investments, Corp. — 53. 5x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for HLX: 39. 3% to $14. 00.

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, Helix Energy Solutions Group, Inc.

(HLX) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 78)). Both have compounded well over 10 years (HLX: +37. 9%, CLOV: -66. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (HLX (Energy) and CLOV (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: HLX is a small-cap quality compounder stock; CLOV is a small-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.